Cannabis Controversy


Several weeks back I was doing a little Saturday morning reading before leaving for the workshop I was teaching that morning.  I was looking at the FDA’s website for any current “drug” news related to the herbal products industry (FDA definition of a drug includes all the teas, tinctures, etc that I brew at home to help with my own health)*.  I saw a release from June (2018) about cannabis.  It was in no way related to my workshop but a glaring contradiction caught my attention. I noticed that in June the FDA approved a drug with the isolated cannabidiol compound for use in seizures, but Cannabis sativa (marijuana) is still listed as a Schedule I drug.  Huh?

Continue reading “Cannabis Controversy”